C
Rigel Pharmaceuticals, Inc. RIGL
$19.41 $0.130.67% NASDAQ
Recommendation
Prev Close
$19.28
Volume
105,908
Avg Vol (90D)
253,787
Market Cap
$344.47M
Dividend & Yield
--
52-Week Range
$7.48 - $29.82
P/E (TTM)
20.54
EPS (TTM)
$0.9387
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Walleye Capital LLC Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
4/27/2025 - MarketBeat
Indivior PLC (INDV) Q1 Earnings and Revenues Beat Estimates
4/24/2025 - Zacks Investment Research
Rigel Pharmaceuticals (RIGL, $18.16) price may drop as it broke higher Bollinger Band on Apr 23, 2025
4/24/2025 - Tickeron - Technical Analysis
Rigel Pharmaceuticals (RIGL, $18.16) Stochastic Oscillator left the overbought zone on April 23, 2025
4/24/2025 - Tickeron - Technical Analysis
Rigel Pharmaceuticals (RIGL, $16.93) Aroon Indicator entered a Downtrend on April 21, 2025.
4/22/2025 - Tickeron - Technical Analysis
Renaissance Technologies LLC Grows Stock Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
4/22/2025 - MarketBeat
Vanguard Group Inc. Grows Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)
4/19/2025 - MarketBeat
Rigel Pharmaceuticals (RIGL, $16.85) Aroon Indicator entered a Downtrend on April 17, 2025.
4/18/2025 - Tickeron - Stocks
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Holdings Decreased by Kennedy Capital Management LLC
4/18/2025 - MarketBeat
Rigel (RIGL) Upgraded to Buy: What Does It Mean for the Stock?
4/17/2025 - Zacks Investment Research
4 Healthcare Stocks to Buy as the Sector Faces Government Heat
4/17/2025 - Zacks Investment Research
Rigel Pharmaceuticals (RIGL, $16.49) Aroon Indicator entered a Downtrend on April 16, 2025.
4/17/2025 - Tickeron - Stocks
Rigel Pharmaceuticals (RIGL, $17.04) Aroon Indicator entered a Downtrend on April 15, 2025.
4/16/2025 - Tickeron - Technical Analysis
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Recommendation of "Hold" from Brokerages
4/15/2025 - MarketBeat
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Consensus Recommendation of "Hold" by Analysts
4/13/2025 - Ticker Report
Rigel Pharmaceuticals (RIGL, $16.68) RSI Indicator left the oversold zone on April 11, 2025
4/12/2025 - Tickeron - Stocks
Rigel Pharmaceuticals (RIGL, $16.26) RSI Indicator left the oversold zone on April 10, 2025
4/11/2025 - Tickeron - Technical Analysis
Rigel Pharmaceuticals (RIGL, $17.26) Aroon Indicator entered a Downtrend on April 09, 2025.
4/10/2025 - Tickeron - Stocks
Rigel Pharmaceuticals (RIGL, $17.26) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
Rigel Pharmaceuticals (RIGL, $16.37) RSI Indicator left the oversold zone on April 08, 2025
4/9/2025 - Tickeron - Stocks
Rigel Pharmaceuticals (RIGL, $16.37) Aroon Indicator entered a Downtrend on April 08, 2025.
4/9/2025 - Tickeron - Stocks
Rigel Pharmaceuticals (RIGL, $17.04) Aroon Indicator entered a Downtrend on April 07, 2025.
4/8/2025 - Tickeron - Technical Analysis
Rigel Pharmaceuticals (RIGL, $17.24) Aroon Indicator entered a Downtrend on April 04, 2025.
4/5/2025 - Tickeron - Stocks
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
4/4/2025 - Seeking Alpha - Long Ideas
Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability
4/4/2025 - SeekingAlpha
Income Statement
Total Revenue (TTM)
$179.28M
EBITDA (TTM)
$26.42M
EBIT (TTM)
$24.19M
Net Income (TTM)
$17.49M
Balance Sheet
Total Assets (Q)
$163.98M
Total Debt (Q)
$99.95M
Total Liabilities (Q)
$160.69M
Book Value Per Share (Q)
$0.1857
Cash Flow
Cash from Operations (TTM)
$31.47M
Cash from Investing (TTM)
$4.13M
Cash from Financing (TTM)
-$11.64M
Net Change in Cash (TTM)
$23.96M
Filings
Filing Date
Tuesday, March 4, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
2.97
7-Day Total Return
17.71%
30-Day Total Return
-3.58%
60-Day Total Return
-14.12%
90-Day Total Return
2.64%
Year to Date Total Return
12.07%
1-Year Total Return
76.45%
2-Year Total Return
69.52%
3-Year Total Return
-22.98%
5-Year Total Return
14.85%
52-week Low
Jul 05, 2024 - $7.48
52-week High
Nov 12, 2024 - $29.82
Valuation
Market Cap
$344.47M - Small Cap
Enterprise Value
$367.10M
Price/Sales (TTM)
1.93
Price/Book (Q)
103.82
Dividends and Shares
Shares Outstanding
17.99M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.rigel.com
Phone Number
650 624 1100
Address
611 Gateway Boulevard
South San Francisco, CA 94080
Country
United States
Year Founded
1996
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The... more
NASDAQ 04/28/2025 4:00PM Eastern Quotes delayed